Shanghai, China

Xianglei Zhang

This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xianglei Zhang. Retrieved from https://idiyas.com/inventor/xianglei-zhang-3vywic90

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xianglei Zhang: Innovator in Pharmaceutical Chemistry

Introduction

Xianglei Zhang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research and development of novel compounds.

Latest Patents

One of his notable patents is related to a tetrahydroisoquinoline compound, which includes a preparation method, a pharmaceutical composition containing the compound, and its various uses. This invention demonstrates a good inhibitory effect on phosphodiesterase (PDE4). It has potential applications in the prevention, treatment, or auxiliary treatment of multiple diseases associated with the activity or expression of phosphodiesterase, especially those related to immune and inflammatory diseases such as psoriasis and arthritis. He holds 1 patent in this area.

Career Highlights

Xianglei Zhang is affiliated with the Chinese Academy of Sciences, where he conducts his research. His work has been instrumental in advancing the understanding of pharmaceutical compounds and their therapeutic applications.

Collaborations

He has collaborated with notable colleagues, including Yechun Xu and Hong Tao Liu, to further enhance the impact of his research in the scientific community.

Conclusion

Xianglei Zhang's innovative work in the development of pharmaceutical compounds highlights his significant role in addressing critical health issues. His contributions continue to pave the way for advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…